Loading...
Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome
SIMPLE SUMMARY: Many patients with primary central nervous system lymphoma (PCNSL) participate in clinical trials. The inclusion criteria for these trials are largely uniform among various trials on first-line treatment. Therefore, there is a lack of data on therapeutic management and prognostic fac...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8230869/ https://ncbi.nlm.nih.gov/pubmed/34208229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13122934 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|